Crestline Management, LP DNLI Holdings History
Crestline Management, LP's Denali Therapeutics Inc Holding Summary
As of 2025-03-31, Crestline Management, LP held 4.16 Mil shares of Denali Therapeutics Inc(DNLI), totaling $56.57 Mil. This investment constitutes 89.45% of their stock portfolio, and Crestline Management, LP now holds 2.86% of the outstanding Denali Therapeutics Inc(DNLI) stock.
The initial trade took place in 2018Q2. And since then Crestline Management, LP has made 1 purchases of DNLI, at an average price of $29.79, for a total of 27.84 Mil shares. In addition, there have been 19 sales at an average price of $44.43 for 23.67 Mil shares. Based on historical transaction data and DNLI's current price of $14.09, Crestline Management, LP's estimated gain on his DNLI holdings is $281.14 Mil, reflecting a 33.90% gain to date.
Crestline Management, LP DNLI ($14.09) Holding Chart
Crestline Management, LP DNLI ($14.09) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
